Salesforce (CRM)
NYSEInformation TechnologySoftware - ApplicationSnapshot 2026-07-07
$169.51+2.33%
Close 2026-07-07 · 1-day change
Reading CRM? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track CRM free→NYSEInformation TechnologySoftware - ApplicationSnapshot 2026-07-07
Reading CRM? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track CRM free→A long-form read on the 1–3 year hold thesis. Slower and deeper than the daily snapshot — it refreshes only when the evidence moves.
This investment represents a durable compounder with a focus on growth and shareholder returns. The current thesis state is intact, supported by strong recent financial performance and a commitment to returning capital to shareholders.
The market currently prices CRM as cheap compared to its peers, with a medium confidence in its valuation. There is an expectations gap, indicating that the market may not fully account for CRM's recent strong performance and potential growth.
Fundamentals are likely to show continued growth, as management is on track with revenue and cash flow guidance. However, there is an elevated risk level due to the potential for guidance cuts and the recent history of misses in the industry.
The long-term thesis hinges on several factors, including the Fed's interest rate decisions, the performance of sector leaders like SAP and CDNS, and CRM's ability to maintain or improve its guidance. Any cuts in guidance could negatively impact sentiment.
Overall, CRM's position looks stable for the next 1 to 3 years, driven by strong fundamentals and sector support. Not investment advice.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. The latest earnings beat supports the improved outlook. Additionally, Salesforce initiated FY27 operating cash flow growth guidance of 9% to 10%. There are no new threats to the thesis.
as of 2026-07-07
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Why it matters: Closing the Informatica deal will help Salesforce manage data better. This matters for AI growth.
Confirms:The deal closes successfully with all approvals by early FY27.
Disproves:The deal faces delays or does not get the needed approvals.
Why it matters: Showing cash flow growth means good money management and efficiency.
Confirms:Salesforce confirms FY27 operating cash flow growth guidance of 9% to 10%.
Disproves:Salesforce cuts its cash flow growth guidance to less than 9%.
Why it matters: The new accounting officer may change how the company shows its finances.
Confirms one read:There are good changes in financial reporting or better audit results.
Confirms the other:Bad feedback on financial reporting or more audit problems.
Why it matters: Confirming the FY27 revenue guidance shows Salesforce's growth and market trust.
Confirms:Salesforce confirms FY27 revenue guidance of $45.8B to $46.2B in the next earnings call.
Disproves:Salesforce revises FY27 revenue guidance downwards from the current range.
Why it matters: Earnings results will show how revenue and operations perform after the deal.
Confirms one read:Earnings report shows revenue growth above 10% year over year.
Confirms the other:Earnings report shows revenue growth below 5% year over year.
Why it matters: Progress in the $25 billion buyback shows good capital use and returns for shareholders.
Confirms:Salesforce completes at least $10 billion of the share repurchase program by the end of FY26.
Disproves:Salesforce announces delays or cuts in the buyback program.